Table 2.
Associations of serum miR-4534 expression and clinicopathological parameters
| Factors | NO. (n = 126) | MiR-4534 expression | χ2 | P value | |
|---|---|---|---|---|---|
| Low expression (n = 58) | High expression (n = 68) | ||||
| Age (years) | 0.090 | 0.764 | |||
| < 50 | 32 | 14 | 18 | ||
| ≥ 50 | 94 | 44 | 50 | ||
| Tumor size (cm) | 0.753 | 0.385 | |||
| < 4 | 73 | 36 | 37 | ||
| ≥ 4 | 53 | 22 | 31 | ||
| Differentiation | 1.759 | 0.185 | |||
| Well-Moderate | 68 | 35 | 33 | ||
| Poor | 58 | 23 | 35 | ||
| LYM | 6.570 | 0.010 | |||
| Negative | 76 | 42 | 34 | ||
| Positive | 50 | 16 | 34 | ||
| FIGO stage | 7.397 | 0.007 | |||
| I–II | 82 | 45 | 37 | ||
| III–IV | 44 | 13 | 31 | ||
| HR-HPV | 5.000 | 0.025 | |||
| No | 95 | 49 | 45 | ||
| Yes | 31 | 9 | 22 | ||
LYM: lymph node metastasis; FIGO: The Federation International of Gynecology and Obstetrics; HR-HPV: high risk human papillomavirus
P < 0.05 means significant difference